Metacognitive Training-Silver BeWell in Older Adults
Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Mar 6, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called Metacognitive Training-Silver (MCT-Silver) BeWell, which aims to help older adults improve their mental well-being and reduce depressive symptoms. The trial is taking place in community settings, like social-psychiatric centers and nursing homes, and is looking at how well older adults accept and benefit from this training over a period of 10 weeks.
To participate, you need to be at least 60 years old, able to speak German, and willing to join the group sessions. It's important that you can hear and see well enough to take part, and you should have the social skills to engage in group activities. However, individuals with severe depression, thoughts of suicide, or significant cognitive issues, like dementia, are not eligible. If you join, you can expect to attend group sessions designed to enhance your mental skills and well-being, and even if you miss some sessions but complete questionnaires, your responses will still be included in the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed consent
- • Age 60 years or older
- • Sufficient command of the German language
- • Willingness to participate in intervention over a period of 10 weeks (participants who do not attend the intervention, but complete questionnaires will also be included in the analysis)
- • Visual and auditory acuity adequate for participation in group sessions
- • Ability to participate in the group setting (ability to participate in the group setting will be assessed during a screening interview (e.g., adequate social skills)).
- Exclusion Criteria:
- • Acute suicidality as assessed by BDI-II Item 9
- • Dementia (MMSE \< 24) or evidence of severe organic brain dysfunction
About Universitätsklinikum Hamburg Eppendorf
Universitätsklinikum Hamburg-Eppendorf (UKE) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, UKE integrates state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among top-tier researchers, clinicians, and healthcare professionals. The institution is dedicated to improving patient outcomes by conducting rigorous scientific investigations that address critical health challenges, ultimately contributing to the development of novel therapies and enhancing medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamburg, , Germany
Patients applied
Trial Officials
Brooke Viertel, PhD
Principal Investigator
Universitätsklinikum Hamburg-Eppendorf
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported